Government Approves Sale of CPSE Indian Medicines Pharmaceutical Corporation for ₹121 Crore

The government has approved the sale of Indian Medicines Pharmaceutical Corporation Limited (IMPCL), a central public sector enterprise under the Ministry of Ayush. Skymap Pharmaceuticals Private Limited, based in Delhi, was the highest bidder with an offer of ₹121 crore for a 100% stake along with management control.

The decision was cleared by a group of ministers that included the Union Finance Minister, the Road Transport and Highways Minister, and the Minister of State for Ayush. IMPCL was set up in 1978 to manufacture and supply Ayurvedic and other traditional medicines.

This is an example of strategic disinvestment, where the government sells its full stake in a public sector company to a private buyer. The aim is to let private management run the business while the government uses the sale proceeds for other priorities.

Disinvestment of public sector units is an important part of the government’s economic policy. Aspirants should know the difference between strategic disinvestment, where management control is also transferred, and minority stake sales, where the government keeps control.